Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model

Yoshiro Kawada, Norio Ogawa, Masato Asanuma, Akitane Mori

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To clarify the role of neuropeptides in dyskinesia induced by iminodipropionitrile (IDPN), the levels of five representative neuropeptides were examined in discrete regions of the rat brain 4 weeks after intraperitoneal injection of IDPN. The five neuropeptides examined were methionine-enkephalin (Met-Enk), substance P (SP) and somatostatin, which are closely related to extrapyramidal function, and thyrotropin-releasing hormone (TRH) and cholecystokinin octapeptide (CCK-8), which are closely related to the neural mechanism of the dopamine system. IDPN pretreatment significantly increased Met-Enk in the basal ganglia but not SP or somatostatin; however, all three neuropeptide levels were increased in the hindbrain. In IDPN-treated rats, TRH and CCK-8 levels were increased in the nucleus accumbens, and the frontal cortical CCK-8 level was extremely increased. These findings, together with previous reports, suggest that neuropeptides in the basal ganglia, hindbrain and cerebral cortex play important roles in the manifestation of dyskinetic symptoms.

Original languageEnglish
Pages (from-to)103-110
Number of pages8
JournalRegulatory Peptides
Volume55
Issue number1
DOIs
Publication statusPublished - Jan 5 1995

Fingerprint

Dyskinesias
Sincalide
Neuropeptides
Rats
Brain
Methionine Enkephalin
Rhombencephalon
Thyrotropin-Releasing Hormone
Substance P
Somatostatin
Basal Ganglia
Nucleus Accumbens
Intraperitoneal Injections
Cerebral Cortex
Dopamine

Keywords

  • Basal ganglia
  • Dyskinesia
  • Hindbrain
  • Iminodipropionitrile (IDPN)
  • Neuropeptide
  • Serotonin syndrome

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)

Cite this

Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model. / Kawada, Yoshiro; Ogawa, Norio; Asanuma, Masato; Mori, Akitane.

In: Regulatory Peptides, Vol. 55, No. 1, 05.01.1995, p. 103-110.

Research output: Contribution to journalArticle

@article{272b78c6c6af42e38fcc6976de36e546,
title = "Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model",
abstract = "To clarify the role of neuropeptides in dyskinesia induced by iminodipropionitrile (IDPN), the levels of five representative neuropeptides were examined in discrete regions of the rat brain 4 weeks after intraperitoneal injection of IDPN. The five neuropeptides examined were methionine-enkephalin (Met-Enk), substance P (SP) and somatostatin, which are closely related to extrapyramidal function, and thyrotropin-releasing hormone (TRH) and cholecystokinin octapeptide (CCK-8), which are closely related to the neural mechanism of the dopamine system. IDPN pretreatment significantly increased Met-Enk in the basal ganglia but not SP or somatostatin; however, all three neuropeptide levels were increased in the hindbrain. In IDPN-treated rats, TRH and CCK-8 levels were increased in the nucleus accumbens, and the frontal cortical CCK-8 level was extremely increased. These findings, together with previous reports, suggest that neuropeptides in the basal ganglia, hindbrain and cerebral cortex play important roles in the manifestation of dyskinetic symptoms.",
keywords = "Basal ganglia, Dyskinesia, Hindbrain, Iminodipropionitrile (IDPN), Neuropeptide, Serotonin syndrome",
author = "Yoshiro Kawada and Norio Ogawa and Masato Asanuma and Akitane Mori",
year = "1995",
month = "1",
day = "5",
doi = "10.1016/0167-0115(94)00105-7",
language = "English",
volume = "55",
pages = "103--110",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model

AU - Kawada, Yoshiro

AU - Ogawa, Norio

AU - Asanuma, Masato

AU - Mori, Akitane

PY - 1995/1/5

Y1 - 1995/1/5

N2 - To clarify the role of neuropeptides in dyskinesia induced by iminodipropionitrile (IDPN), the levels of five representative neuropeptides were examined in discrete regions of the rat brain 4 weeks after intraperitoneal injection of IDPN. The five neuropeptides examined were methionine-enkephalin (Met-Enk), substance P (SP) and somatostatin, which are closely related to extrapyramidal function, and thyrotropin-releasing hormone (TRH) and cholecystokinin octapeptide (CCK-8), which are closely related to the neural mechanism of the dopamine system. IDPN pretreatment significantly increased Met-Enk in the basal ganglia but not SP or somatostatin; however, all three neuropeptide levels were increased in the hindbrain. In IDPN-treated rats, TRH and CCK-8 levels were increased in the nucleus accumbens, and the frontal cortical CCK-8 level was extremely increased. These findings, together with previous reports, suggest that neuropeptides in the basal ganglia, hindbrain and cerebral cortex play important roles in the manifestation of dyskinetic symptoms.

AB - To clarify the role of neuropeptides in dyskinesia induced by iminodipropionitrile (IDPN), the levels of five representative neuropeptides were examined in discrete regions of the rat brain 4 weeks after intraperitoneal injection of IDPN. The five neuropeptides examined were methionine-enkephalin (Met-Enk), substance P (SP) and somatostatin, which are closely related to extrapyramidal function, and thyrotropin-releasing hormone (TRH) and cholecystokinin octapeptide (CCK-8), which are closely related to the neural mechanism of the dopamine system. IDPN pretreatment significantly increased Met-Enk in the basal ganglia but not SP or somatostatin; however, all three neuropeptide levels were increased in the hindbrain. In IDPN-treated rats, TRH and CCK-8 levels were increased in the nucleus accumbens, and the frontal cortical CCK-8 level was extremely increased. These findings, together with previous reports, suggest that neuropeptides in the basal ganglia, hindbrain and cerebral cortex play important roles in the manifestation of dyskinetic symptoms.

KW - Basal ganglia

KW - Dyskinesia

KW - Hindbrain

KW - Iminodipropionitrile (IDPN)

KW - Neuropeptide

KW - Serotonin syndrome

UR - http://www.scopus.com/inward/record.url?scp=0028890742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028890742&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(94)00105-7

DO - 10.1016/0167-0115(94)00105-7

M3 - Article

C2 - 7536949

AN - SCOPUS:0028890742

VL - 55

SP - 103

EP - 110

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1

ER -